JP2009232853A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009232853A5 JP2009232853A5 JP2009136863A JP2009136863A JP2009232853A5 JP 2009232853 A5 JP2009232853 A5 JP 2009232853A5 JP 2009136863 A JP2009136863 A JP 2009136863A JP 2009136863 A JP2009136863 A JP 2009136863A JP 2009232853 A5 JP2009232853 A5 JP 2009232853A5
- Authority
- JP
- Japan
- Prior art keywords
- hsc
- progeny
- hyaluronic acid
- antagonist
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 11
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 9
- 229920002674 hyaluronan Polymers 0.000 claims 9
- 229960003160 hyaluronic acid Drugs 0.000 claims 9
- 102000018866 Hyaluronan Receptors Human genes 0.000 claims 4
- 108010013214 Hyaluronan Receptors Proteins 0.000 claims 4
- 108010003272 Hyaluronate lyase Proteins 0.000 claims 4
- 102000001974 Hyaluronidases Human genes 0.000 claims 4
- 239000005557 antagonist Substances 0.000 claims 4
- 229960002773 hyaluronidase Drugs 0.000 claims 4
- 239000003112 inhibitor Substances 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 3
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims 2
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims 2
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 230000004069 differentiation Effects 0.000 claims 2
- 230000035755 proliferation Effects 0.000 claims 2
- 208000031261 Acute myeloid leukaemia Diseases 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR8565A AUPR856501A0 (en) | 2001-10-30 | 2001-10-30 | Detection of haematopoietic stem cells and progeny and uses thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003540336A Division JP4354275B2 (ja) | 2001-10-30 | 2002-10-24 | 造血幹細胞およびその子孫の検出およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009232853A JP2009232853A (ja) | 2009-10-15 |
| JP2009232853A5 true JP2009232853A5 (enExample) | 2009-11-26 |
Family
ID=3832387
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003540336A Expired - Fee Related JP4354275B2 (ja) | 2001-10-30 | 2002-10-24 | 造血幹細胞およびその子孫の検出およびその使用 |
| JP2009136863A Pending JP2009232853A (ja) | 2001-10-30 | 2009-06-08 | 造血幹細胞およびその子孫の検出およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003540336A Expired - Fee Related JP4354275B2 (ja) | 2001-10-30 | 2002-10-24 | 造血幹細胞およびその子孫の検出およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20050003460A1 (enExample) |
| EP (1) | EP1451303A4 (enExample) |
| JP (2) | JP4354275B2 (enExample) |
| AU (2) | AUPR856501A0 (enExample) |
| CA (1) | CA2464956A1 (enExample) |
| IL (2) | IL161690A0 (enExample) |
| WO (1) | WO2003038071A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030228635A1 (en) * | 2002-02-15 | 2003-12-11 | Renovar, Inc. | Cell proliferation assays and methods |
| US20100145032A1 (en) * | 2007-01-18 | 2010-06-10 | Suomen Punainen Risti, Veripalelu | Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof |
| WO2012048298A2 (en) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions |
| JP6057574B2 (ja) | 2012-07-11 | 2017-01-11 | キヤノン株式会社 | 造血幹細胞識別用プローブ |
| WO2015073918A1 (en) | 2013-11-16 | 2015-05-21 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
| US11008547B2 (en) | 2014-03-25 | 2021-05-18 | Terumo Bct, Inc. | Passive replacement of media |
| WO2016049421A1 (en) | 2014-09-26 | 2016-03-31 | Terumo Bct, Inc. | Scheduled feed |
| WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
| US20170318781A1 (en) * | 2016-05-03 | 2017-11-09 | Cattle Time, Llc | Combined visual and rf identification (rfid) tag |
| US11965175B2 (en) | 2016-05-25 | 2024-04-23 | Terumo Bct, Inc. | Cell expansion |
| US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
| US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
| US11629332B2 (en) | 2017-03-31 | 2023-04-18 | Terumo Bct, Inc. | Cell expansion |
| US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
| US12234441B2 (en) | 2017-03-31 | 2025-02-25 | Terumo Bct, Inc. | Cell expansion |
| GB2619893A (en) | 2021-03-23 | 2023-12-20 | Terumo Bct Inc | Cell capture and expansion |
| US12209689B2 (en) | 2022-02-28 | 2025-01-28 | Terumo Kabushiki Kaisha | Multiple-tube pinch valve assembly |
| USD1099116S1 (en) | 2022-09-01 | 2025-10-21 | Terumo Bct, Inc. | Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6875753B1 (en) * | 1996-03-14 | 2005-04-05 | The Governors Of The University Of Alberta | Methods for cell mobilization using in vivo treatment with hyaluronan (HA) |
| CA2324624A1 (en) * | 1998-03-13 | 1999-09-16 | Shawn J. Green | Metastatin and hyaluronate binding proteins and methods of use |
| WO2000017326A1 (en) | 1998-09-21 | 2000-03-30 | Musc Foundation For Research Development | Non-hematopoietic cells, including cardiomyocytes and skeletal muscle cells, derived from hematopoietic stem cells and methods of making and using them |
| FR2789587B1 (fr) * | 1999-02-11 | 2003-01-24 | Inst Nat Sante Rech Med | Moyens pour la regulation de la differenciation hematopoietique |
| US20030032621A1 (en) * | 2000-02-11 | 2003-02-13 | Florence Smadja-Joffe | Means for regulating hematopoietic differentiation |
| WO2002044345A1 (en) * | 2000-12-01 | 2002-06-06 | The General Hospital Corporation | Methods and products for manipulating hematopoietic stem cells |
-
2001
- 2001-10-30 AU AUPR8565A patent/AUPR856501A0/en not_active Abandoned
-
2002
- 2002-10-24 CA CA002464956A patent/CA2464956A1/en not_active Abandoned
- 2002-10-24 EP EP02769779A patent/EP1451303A4/en not_active Withdrawn
- 2002-10-24 AU AU2002335921A patent/AU2002335921B2/en not_active Ceased
- 2002-10-24 IL IL16169002A patent/IL161690A0/xx unknown
- 2002-10-24 WO PCT/AU2002/001443 patent/WO2003038071A1/en not_active Ceased
- 2002-10-24 JP JP2003540336A patent/JP4354275B2/ja not_active Expired - Fee Related
-
2004
- 2004-04-30 US US10/837,038 patent/US20050003460A1/en not_active Abandoned
-
2007
- 2007-11-01 US US11/933,633 patent/US7718379B2/en not_active Expired - Fee Related
-
2009
- 2009-06-08 JP JP2009136863A patent/JP2009232853A/ja active Pending
-
2010
- 2010-03-19 US US12/727,697 patent/US20110020314A1/en not_active Abandoned
- 2010-04-28 IL IL205407A patent/IL205407A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009232853A5 (enExample) | ||
| WO2017100467A3 (en) | Compositions and methods for internalizing enzymes | |
| MX2009011949A (es) | Inhibidores de proteina activadora de 5-lipoxigenasa (flap). | |
| JP2007523049A5 (enExample) | ||
| HK1199725A1 (en) | Heterocyclic compounds and uses thereof | |
| SG166813A1 (en) | 5-lipoxygenase-activating protein (flap) inhibitors | |
| WO2009129335A3 (en) | Selective inhibitors of histone deacetylase | |
| WO2008079460A3 (en) | Tyrosine kinase inhibitors for prevention or treatment of infection | |
| NO20092444L (no) | Heteroarylamidderivater | |
| BR112013023774A2 (pt) | inibidores de glicosilceramida sintase | |
| WO2016138534A3 (en) | Antisense-induced exon2 inclusion in acid alpha-glucosidase | |
| MX2007016462A (es) | Composiciones topicas para tratar la piel. | |
| JP2008505181A5 (enExample) | ||
| MY155961A (en) | Chemical compounds 251 | |
| EA201001329A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| SG165387A1 (en) | 5-lipoxygenase-activating protein (flap) inhibitors | |
| WO2015077503A8 (en) | Autotaxin inhibitor compounds | |
| RU2009118942A (ru) | Способ стимуляции регенерации тканей | |
| CL2008003201A1 (es) | Composicion farmaceutica que comprende 0,5 a 50 mg de gaboxadol o una sal farmaceuticamente aceptable de este, y uno o mas inhibidores de pat1 y/o uno o mas inhibidores de oat, en donde dicha composicion brinda un perfil plasmatico in vivo con un tmax superior a 20 minutos, util en tratamientos de trastornos del sueno. | |
| EA201001330A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| BR112014010729A2 (pt) | métodos para tratamento de ataques de gota | |
| WO2016100738A3 (en) | Antifibrotic activity of gas6 inhibitor | |
| BRPI0821373B8 (pt) | composições farmacêuticas contendo ao menos um princípio ativo protéico protegido de enzimas digestivas | |
| WO2011096756A3 (ko) | 비정상적 세포 증식 억제용 약제학적 조성물 | |
| MY144970A (en) | Heterocyclic compounds |